SQA
ABUS icon

Simon Quick Advisors’s Arbutus Biopharma ABUS Stock Holding History

Simon Quick Advisors’s Portfolio ABUS Stock Details ABUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-100
Closed – – 181
2022
Q1 		$0 Hold
100
– – ﹤0.01% 346
2021
Q4 		$0 Hold
100
– – ﹤0.01% 363
2021
Q3 		$0 Hold
100
– – ﹤0.01% 415
2021
Q2 		$0 Hold
100
– – ﹤0.01% 438
2021
Q1 		$0 Hold
100
– – ﹤0.01% 439
2020
Q4 		$0 Hold
100
– – ﹤0.01% 429
2020
Q3 		$0 Hold
100
– – ﹤0.01% 441
2020
Q2 		$0 Hold
100
– – ﹤0.01% 441
2020
Q1 		$1K Hold
100
– – ﹤0.01% 433
2019
Q4 		$0 Hold
100
– – ﹤0.01% 654
2019
Q3 		$0 Hold
100
– – ﹤0.01% 366
2019
Q2 		$208 Buy
+100
New +$256 ﹤0.01% 464

Other funds holding ABUS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BC
Brookfield Corp Toronto, Ontario, Canada $74.2B AUM 0.68% 1-Year Est. Return
FCM
FourWorld Capital Management New York $196M AUM 42.39% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Simon Quick Advisors's ABUS Position: Q2 2022 in Review

Simon Quick Advisors sold out of Arbutus Biopharma (ABUS) in Q2 2022, closing a stake of 100 shares.

Simon Quick Advisors first reported a position in ABUS in Q2 2019 and held it in 12 quarters. The position peaked at $1K in Q1 2020. 113 funds tracked by Wall St. Rank hold ABUS as of Q2 2022.

  • Simon Quick Advisors reported no remaining Arbutus Biopharma position as of Q2 2022 after selling out during the quarter.
  • Simon Quick Advisors sold 100 Arbutus Biopharma shares in Q2 2022.
  • Simon Quick Advisors first reported a position in Arbutus Biopharma in Q2 2019 and held it in 12 quarters.
  • Simon Quick Advisors's Arbutus Biopharma position peaked at $1K in Q1 2020.
  • 113 funds tracked by Wall St. Rank held Arbutus Biopharma as of Q2 2022.

Based on Simon Quick Advisors's 13F filing for Q2 2022, filed 8 Aug 2022.